New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 23, 2014
08:08 EDTWWWW, SONS, SIRI, FUN, NVAX, AEGR, WRLD, NRF, ORN, ORB, NCS, DY, CR, PLCE, BIG, SPLKSplunk, Big Lots on FBR's list of stocks that can double
FBR Capital compiled a list of stocks it believes can double within two years. The names on the list are: Big Lots (BIG), Children's Place (PLCE), Crane (CR), Dycom (DY), NCI Building Systems (NCS), Orbital Sciences (ORB), Orion Marine (ORN), Northstar Realty (NRF), World Acceptance (WRLD), Aegerion (AEGR), Novavax (NVAX), Cedar Fair (FUN), Sirius XM (SIRI), Sonus Networks (SONS), Splunk (SPLK) and (WWWW).
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
October 27, 2014
17:16 EDTCRCrane lowers FY14 EPS view to $4.40-$4.50 from $4.55-$4.75, consensus $4.62
Subscribe for More Information
17:13 EDTCRCrane reports Q3 EPS ex-items $1.12, consensus $1.17
Reports Q3 revenue $727.41M, consensus $769.68M.
16:36 EDTNVAXOn The Fly: Closing Wrap
Subscribe for More Information
15:36 EDTSIRINotable companies reporting before tomorrow's open
Subscribe for More Information
11:24 EDTNVAXNovavax rises after announcing Ebola vaccine development program
Subscribe for More Information
10:52 EDTAEGRSeattle Genetics, Aegerion CEOs accused of drug use in lawsuit, TheStreet says
Subscribe for More Information
09:14 EDTNVAXOn The Fly: Pre-market Movers
Subscribe for More Information
07:38 EDTNVAXNovavax announces Ebola vaccine development program
Subscribe for More Information
October 26, 2014
15:10 EDTORBOrbital set to launch cargo delivery mission to International Space Station
Orbital Sciences announced that it is prepared to launch the company’s AntaresTM rocket carrying a CygnusTM cargo logistics spacecraft destined for the International Space Station, ISS, under the Commercial Resupply Services, CRS, contract with NASA. Pending completion of final vehicle testing and acceptable local weather conditions, the launch of the Orb-3 mission will take place on Monday, October 27, with lift-off scheduled for 6:45 p.m.from the Mid-Atlantic Regional Spaceport located at NASA’s Wallops Flight Facility in eastern Virginia. The Antares medium-class rocket will boost the Cygnus spacecraft into a targeted orbit of approximately 125 x 185 miles above the Earth, inclined at 51.6 degrees to the equator. Following in-orbit activation and testing after launch, Cygnus is slated to rendezvous and berth with the ISS on November 2.Under its $1.9B CRS contract with NASA, Orbital will use Antares and Cygnus to deliver up to 44,000 pounds of cargo to the ISS over eight missions through 2016. For each mission, NASA will manifest a variety of essential items based on ISS program needs, including food, clothing, crew supplies, spare parts and equipment, and scientific experiments.
12:58 EDTNVAXNovavax presents RSV F protein nanoparticle vaccine clinical data
Novavax announced that Gregory Glenn, M.D., SVP, Research and Development is presenting new immunogenicity data from Novavax' RSV F-Protein Nanoparticle vaccine candidate, RSV F vaccine, clinical trials at the 8th Vaccine & ISV Congress in Philadelphia.
October 23, 2014
07:15 EDTSONSSonus sees FY14 EPS 7c, consensus 7c
Subscribe for More Information
07:14 EDTSONSSonus sees Q4 EPS 3c, consensus 3c
Subscribe for More Information
07:13 EDTSONSSonus reports Q3 EPS 1c, consensus 1c
Reports Q3 revenue $73.2M, consensus $71.97M.
October 22, 2014
07:35 EDTAEGRCardiometabolic Health Congress to hold annual meeting
Subscribe for More Information
06:31 EDTWRLDWorld Acceptance experienced lower growth rates due to lower demand in US
Gross loans amounted to $1.19 billion at September 30, 2014, a 2.6% increase over the $1.16 billion outstanding at September 30, 2013, and a 9.0% increase since the beginning of the fiscal year.
06:31 EDTWRLDWorld Acceptance reports Q2 EPS $2.16, consensus $2.30
Subscribe for More Information
October 20, 2014
07:24 EDTAEGRAegerion price target lowered to $46 from $66 at Leerink
Leerink lowered its price target for Aegerion shares to $46 after its survey of 40 U.S. cardiologists implied a more bearish outlook for Juxtapid once PCSK9s emerge. The firm, however, believes new patient adds are well outpacing Juxtapid discontinuations in the near term. It keeps an Outperform rating on the stock.
October 17, 2014
10:00 EDTBIGOn The Fly: Analyst Initiation Summary
Subscribe for More Information
08:28 EDTNVAXNovavax management to meet with JPMorgan
Subscribe for More Information
08:11 EDTBIGBig Lots initiated with a Buy at Stifel
Target $58.
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use